CD274 and breast cancer: However, among patients with PD-L1-negative breast cancer, survival in the high CD8-positive TIL expression group was significantly longer than that in the low CD8-positive TIL expression group (hazard ratio = 4.58, 95% CI 1.66–12.67, p = 0.0033; Fig. 3b).